 | • レポートコード：MRC2-11QY08028 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は鼻ポリポーシス治療薬のグローバル市場について調査・分析したレポートです。種類別（AK-001、デュピルマブ、プロピオン酸フルチカゾン、イフェトロバンナトリウム、オマリズマブ、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別鼻ポリポーシス治療薬の競争状況、市場シェア ・世界の鼻ポリポーシス治療薬市場：種類別市場規模 2015年-2020年（AK-001、デュピルマブ、プロピオン酸フルチカゾン、イフェトロバンナトリウム、オマリズマブ、その他） ・世界の鼻ポリポーシス治療薬市場：種類別市場規模予測 2021年-2026年（AK-001、デュピルマブ、プロピオン酸フルチカゾン、イフェトロバンナトリウム、オマリズマブ、その他） ・世界の鼻ポリポーシス治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の鼻ポリポーシス治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の鼻ポリポーシス治療薬市場分析：米国、カナダ ・ヨーロッパの鼻ポリポーシス治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの鼻ポリポーシス治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の鼻ポリポーシス治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの鼻ポリポーシス治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allakos Inc、Cumberland Pharmaceuticals Inc、F. Hoffmann-La Roche Ltd、OptiNose US Inc、Regeneron Pharmaceuticals Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Nasal Polyposis Drug Market
The global Nasal Polyposis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Nasal Polyposis Drug Scope and Market Size
Nasal Polyposis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nasal Polyposis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Nasal Polyposis Drug market is segmented into
AK-001
Dupilumab
Fluticasone Propionate
Ifetroban Sodium
Omalizumab
Others
Segment by Application, the Nasal Polyposis Drug market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Nasal Polyposis Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nasal Polyposis Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nasal Polyposis Drug Market Share Analysis
Nasal Polyposis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nasal Polyposis Drug business, the date to enter into the Nasal Polyposis Drug market, Nasal Polyposis Drug product introduction, recent developments, etc.
The major vendors covered:
Allakos Inc
Cumberland Pharmaceuticals Inc
F. Hoffmann-La Roche Ltd
OptiNose US Inc
Regeneron Pharmaceuticals Inc
…
1 Study Coverage
1.1 Nasal Polyposis Drug Product Introduction
1.2 Market Segments
1.3 Key Nasal Polyposis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Nasal Polyposis Drug Market Size Growth Rate by Type
1.4.2 AK-001
1.4.3 Dupilumab
1.4.4 Fluticasone Propionate
1.4.5 Ifetroban Sodium
1.4.6 Omalizumab
1.4.7 Others
1.5 Market by Application
1.5.1 Global Nasal Polyposis Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Nasal Polyposis Drug Market Size, Estimates and Forecasts
2.1.1 Global Nasal Polyposis Drug Revenue 2015-2026
2.1.2 Global Nasal Polyposis Drug Sales 2015-2026
2.2 Global Nasal Polyposis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Nasal Polyposis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Nasal Polyposis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Nasal Polyposis Drug Competitor Landscape by Players
3.1 Nasal Polyposis Drug Sales by Manufacturers
3.1.1 Nasal Polyposis Drug Sales by Manufacturers (2015-2020)
3.1.2 Nasal Polyposis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Nasal Polyposis Drug Revenue by Manufacturers
3.2.1 Nasal Polyposis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Nasal Polyposis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nasal Polyposis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Nasal Polyposis Drug Revenue in 2019
3.2.5 Global Nasal Polyposis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Nasal Polyposis Drug Price by Manufacturers
3.4 Nasal Polyposis Drug Manufacturing Base Distribution, Product Types
3.4.1 Nasal Polyposis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nasal Polyposis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Nasal Polyposis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Nasal Polyposis Drug Market Size by Type (2015-2020)
4.1.1 Global Nasal Polyposis Drug Sales by Type (2015-2020)
4.1.2 Global Nasal Polyposis Drug Revenue by Type (2015-2020)
4.1.3 Nasal Polyposis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Nasal Polyposis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Nasal Polyposis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Nasal Polyposis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Nasal Polyposis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Nasal Polyposis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Nasal Polyposis Drug Market Size by Application (2015-2020)
5.1.1 Global Nasal Polyposis Drug Sales by Application (2015-2020)
5.1.2 Global Nasal Polyposis Drug Revenue by Application (2015-2020)
5.1.3 Nasal Polyposis Drug Price by Application (2015-2020)
5.2 Nasal Polyposis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Nasal Polyposis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Nasal Polyposis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Nasal Polyposis Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Nasal Polyposis Drug by Country
6.1.1 North America Nasal Polyposis Drug Sales by Country
6.1.2 North America Nasal Polyposis Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Nasal Polyposis Drug Market Facts & Figures by Type
6.3 North America Nasal Polyposis Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Nasal Polyposis Drug by Country
7.1.1 Europe Nasal Polyposis Drug Sales by Country
7.1.2 Europe Nasal Polyposis Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nasal Polyposis Drug Market Facts & Figures by Type
7.3 Europe Nasal Polyposis Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Nasal Polyposis Drug by Region
8.1.1 Asia Pacific Nasal Polyposis Drug Sales by Region
8.1.2 Asia Pacific Nasal Polyposis Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Nasal Polyposis Drug Market Facts & Figures by Type
8.3 Asia Pacific Nasal Polyposis Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Nasal Polyposis Drug by Country
9.1.1 Latin America Nasal Polyposis Drug Sales by Country
9.1.2 Latin America Nasal Polyposis Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Nasal Polyposis Drug Market Facts & Figures by Type
9.3 Central & South America Nasal Polyposis Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Nasal Polyposis Drug by Country
10.1.1 Middle East and Africa Nasal Polyposis Drug Sales by Country
10.1.2 Middle East and Africa Nasal Polyposis Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Nasal Polyposis Drug Market Facts & Figures by Type
10.3 Middle East and Africa Nasal Polyposis Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Allakos Inc
11.1.1 Allakos Inc Corporation Information
11.1.2 Allakos Inc Description and Business Overview
11.1.3 Allakos Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allakos Inc Nasal Polyposis Drug Products Offered
11.1.5 Allakos Inc Related Developments
11.2 Cumberland Pharmaceuticals Inc
11.2.1 Cumberland Pharmaceuticals Inc Corporation Information
11.2.2 Cumberland Pharmaceuticals Inc Description and Business Overview
11.2.3 Cumberland Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Cumberland Pharmaceuticals Inc Nasal Polyposis Drug Products Offered
11.2.5 Cumberland Pharmaceuticals Inc Related Developments
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Corporation Information
11.3.2 F. Hoffmann-La Roche Ltd Description and Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 F. Hoffmann-La Roche Ltd Nasal Polyposis Drug Products Offered
11.3.5 F. Hoffmann-La Roche Ltd Related Developments
11.4 OptiNose US Inc
11.4.1 OptiNose US Inc Corporation Information
11.4.2 OptiNose US Inc Description and Business Overview
11.4.3 OptiNose US Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 OptiNose US Inc Nasal Polyposis Drug Products Offered
11.4.5 OptiNose US Inc Related Developments
11.5 Regeneron Pharmaceuticals Inc
11.5.1 Regeneron Pharmaceuticals Inc Corporation Information
11.5.2 Regeneron Pharmaceuticals Inc Description and Business Overview
11.5.3 Regeneron Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Regeneron Pharmaceuticals Inc Nasal Polyposis Drug Products Offered
11.5.5 Regeneron Pharmaceuticals Inc Related Developments
11.1 Allakos Inc
11.1.1 Allakos Inc Corporation Information
11.1.2 Allakos Inc Description and Business Overview
11.1.3 Allakos Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allakos Inc Nasal Polyposis Drug Products Offered
11.1.5 Allakos Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Nasal Polyposis Drug Market Estimates and Projections by Region
12.1.1 Global Nasal Polyposis Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Nasal Polyposis Drug Revenue Forecast by Regions 2021-2026
12.2 North America Nasal Polyposis Drug Market Size Forecast (2021-2026)
12.2.1 North America: Nasal Polyposis Drug Sales Forecast (2021-2026)
12.2.2 North America: Nasal Polyposis Drug Revenue Forecast (2021-2026)
12.2.3 North America: Nasal Polyposis Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Nasal Polyposis Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Nasal Polyposis Drug Sales Forecast (2021-2026)
12.3.2 Europe: Nasal Polyposis Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Nasal Polyposis Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Nasal Polyposis Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Nasal Polyposis Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Nasal Polyposis Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Nasal Polyposis Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Nasal Polyposis Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Nasal Polyposis Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Nasal Polyposis Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Nasal Polyposis Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Nasal Polyposis Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Nasal Polyposis Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Nasal Polyposis Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Nasal Polyposis Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Nasal Polyposis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nasal Polyposis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Nasal Polyposis Drug Market Segments
Table 2. Ranking of Global Top Nasal Polyposis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nasal Polyposis Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AK-001
Table 5. Major Manufacturers of Dupilumab
Table 6. Major Manufacturers of Fluticasone Propionate
Table 7. Major Manufacturers of Ifetroban Sodium
Table 8. Major Manufacturers of Omalizumab
Table 9. Major Manufacturers of Others
Table 10. Global Nasal Polyposis Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Nasal Polyposis Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Nasal Polyposis Drug Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Nasal Polyposis Drug Sales Market Share by Regions (2015-2020)
Table 14. Global Nasal Polyposis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Nasal Polyposis Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Nasal Polyposis Drug Sales Share by Manufacturers (2015-2020)
Table 17. Global Nasal Polyposis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Nasal Polyposis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasal Polyposis Drug as of 2019)
Table 19. Nasal Polyposis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Nasal Polyposis Drug Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Nasal Polyposis Drug Price (2015-2020) (USD/Pcs)
Table 22. Nasal Polyposis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Nasal Polyposis Drug Product Type
Table 24. Date of International Manufacturers Enter into Nasal Polyposis Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Nasal Polyposis Drug Sales by Type (2015-2020) (K Pcs)
Table 27. Global Nasal Polyposis Drug Sales Share by Type (2015-2020)
Table 28. Global Nasal Polyposis Drug Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Nasal Polyposis Drug Revenue Share by Type (2015-2020)
Table 30. Nasal Polyposis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Nasal Polyposis Drug Sales by Application (2015-2020) (K Pcs)
Table 32. Global Nasal Polyposis Drug Sales Share by Application (2015-2020)
Table 33. North America Nasal Polyposis Drug Sales by Country (2015-2020) (K Pcs)
Table 34. North America Nasal Polyposis Drug Sales Market Share by Country (2015-2020)
Table 35. North America Nasal Polyposis Drug Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Nasal Polyposis Drug Revenue Market Share by Country (2015-2020)
Table 37. North America Nasal Polyposis Drug Sales by Type (2015-2020) (K Pcs)
Table 38. North America Nasal Polyposis Drug Sales Market Share by Type (2015-2020)
Table 39. North America Nasal Polyposis Drug Sales by Application (2015-2020) (K Pcs)
Table 40. North America Nasal Polyposis Drug Sales Market Share by Application (2015-2020)
Table 41. Europe Nasal Polyposis Drug Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Nasal Polyposis Drug Sales Market Share by Country (2015-2020)
Table 43. Europe Nasal Polyposis Drug Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Nasal Polyposis Drug Revenue Market Share by Country (2015-2020)
Table 45. Europe Nasal Polyposis Drug Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Nasal Polyposis Drug Sales Market Share by Type (2015-2020)
Table 47. Europe Nasal Polyposis Drug Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Nasal Polyposis Drug Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Nasal Polyposis Drug Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Nasal Polyposis Drug Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Nasal Polyposis Drug Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Nasal Polyposis Drug Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Nasal Polyposis Drug Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Nasal Polyposis Drug Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Nasal Polyposis Drug Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Nasal Polyposis Drug Sales Market Share by Application (2015-2020)
Table 57. Latin America Nasal Polyposis Drug Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Nasal Polyposis Drug Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Nasal Polyposis Drug Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Nasal Polyposis Drug Revenue Market Share by Country (2015-2020)
Table 61. Latin America Nasal Polyposis Drug Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Nasal Polyposis Drug Sales Market Share by Type (2015-2020)
Table 63. Latin America Nasal Polyposis Drug Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Nasal Polyposis Drug Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Nasal Polyposis Drug Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Nasal Polyposis Drug Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Nasal Polyposis Drug Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Nasal Polyposis Drug Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Nasal Polyposis Drug Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Nasal Polyposis Drug Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Nasal Polyposis Drug Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Nasal Polyposis Drug Sales Market Share by Application (2015-2020)
Table 73. Allakos Inc Corporation Information
Table 74. Allakos Inc Description and Major Businesses
Table 75. Allakos Inc Nasal Polyposis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Allakos Inc Product
Table 77. Allakos Inc Recent Development
Table 78. Cumberland Pharmaceuticals Inc Corporation Information
Table 79. Cumberland Pharmaceuticals Inc Description and Major Businesses
Table 80. Cumberland Pharmaceuticals Inc Nasal Polyposis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Cumberland Pharmaceuticals Inc Product
Table 82. Cumberland Pharmaceuticals Inc Recent Development
Table 83. F. Hoffmann-La Roche Ltd Corporation Information
Table 84. F. Hoffmann-La Roche Ltd Description and Major Businesses
Table 85. F. Hoffmann-La Roche Ltd Nasal Polyposis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. F. Hoffmann-La Roche Ltd Product
Table 87. F. Hoffmann-La Roche Ltd Recent Development
Table 88. OptiNose US Inc Corporation Information
Table 89. OptiNose US Inc Description and Major Businesses
Table 90. OptiNose US Inc Nasal Polyposis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. OptiNose US Inc Product
Table 92. OptiNose US Inc Recent Development
Table 93. Regeneron Pharmaceuticals Inc Corporation Information
Table 94. Regeneron Pharmaceuticals Inc Description and Major Businesses
Table 95. Regeneron Pharmaceuticals Inc Nasal Polyposis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Regeneron Pharmaceuticals Inc Product
Table 97. Regeneron Pharmaceuticals Inc Recent Development
Table 98. Global Nasal Polyposis Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 99. Global Nasal Polyposis Drug Sales Market Share Forecast by Regions (2021-2026)
Table 100. Global Nasal Polyposis Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 101. Global Nasal Polyposis Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 102. North America: Nasal Polyposis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. North America: Nasal Polyposis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Europe: Nasal Polyposis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. Europe: Nasal Polyposis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Asia Pacific: Nasal Polyposis Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 107. Asia Pacific: Nasal Polyposis Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 108. Latin America: Nasal Polyposis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Latin America: Nasal Polyposis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Middle East and Africa: Nasal Polyposis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 111. Middle East and Africa: Nasal Polyposis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 113. Key Challenges
Table 114. Market Risks
Table 115. Main Points Interviewed from Key Nasal Polyposis Drug Players
Table 116. Nasal Polyposis Drug Customers List
Table 117. Nasal Polyposis Drug Distributors List
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Nasal Polyposis Drug Product Picture
Figure 2. Global Nasal Polyposis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. AK-001 Product Picture
Figure 4. Dupilumab Product Picture
Figure 5. Fluticasone Propionate Product Picture
Figure 6. Ifetroban Sodium Product Picture
Figure 7. Omalizumab Product Picture
Figure 8. Others Product Picture
Figure 9. Global Nasal Polyposis Drug Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Nasal Polyposis Drug Report Years Considered
Figure 14. Global Nasal Polyposis Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Nasal Polyposis Drug Sales 2015-2026 (K Pcs)
Figure 16. Global Nasal Polyposis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Nasal Polyposis Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Nasal Polyposis Drug Sales Market Share by Region in 2019
Figure 19. Global Nasal Polyposis Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Nasal Polyposis Drug Revenue Market Share by Region in 2019
Figure 21. Global Nasal Polyposis Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Nasal Polyposis Drug Revenue in 2019
Figure 23. Nasal Polyposis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Nasal Polyposis Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Nasal Polyposis Drug Sales Market Share by Type in 2019
Figure 26. Global Nasal Polyposis Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Nasal Polyposis Drug Revenue Market Share by Type in 2019
Figure 28. Global Nasal Polyposis Drug Market Share by Price Range (2015-2020)
Figure 29. Global Nasal Polyposis Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Nasal Polyposis Drug Sales Market Share by Application in 2019
Figure 31. Global Nasal Polyposis Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Nasal Polyposis Drug Revenue Market Share by Application in 2019
Figure 33. North America Nasal Polyposis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Nasal Polyposis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Nasal Polyposis Drug Sales Market Share by Country in 2019
Figure 36. North America Nasal Polyposis Drug Revenue Market Share by Country in 2019
Figure 37. U.S. Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Nasal Polyposis Drug Market Share by Type in 2019
Figure 42. North America Nasal Polyposis Drug Market Share by Application in 2019
Figure 43. Europe Nasal Polyposis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Nasal Polyposis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Nasal Polyposis Drug Sales Market Share by Country in 2019
Figure 46. Europe Nasal Polyposis Drug Revenue Market Share by Country in 2019
Figure 47. Germany Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Nasal Polyposis Drug Market Share by Type in 2019
Figure 58. Europe Nasal Polyposis Drug Market Share by Application in 2019
Figure 59. Asia Pacific Nasal Polyposis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Nasal Polyposis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Nasal Polyposis Drug Sales Market Share by Region in 2019
Figure 62. Asia Pacific Nasal Polyposis Drug Revenue Market Share by Region in 2019
Figure 63. China Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Nasal Polyposis Drug Market Share by Type in 2019
Figure 86. Asia Pacific Nasal Polyposis Drug Market Share by Application in 2019
Figure 87. Latin America Nasal Polyposis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Nasal Polyposis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Nasal Polyposis Drug Sales Market Share by Country in 2019
Figure 90. Latin America Nasal Polyposis Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Nasal Polyposis Drug Market Share by Type in 2019
Figure 98. Latin America Nasal Polyposis Drug Market Share by Application in 2019
Figure 99. Middle East and Africa Nasal Polyposis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Nasal Polyposis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Nasal Polyposis Drug Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Nasal Polyposis Drug Revenue Market Share by Country in 2019
Figure 103. Turkey Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Nasal Polyposis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Nasal Polyposis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Nasal Polyposis Drug Market Share by Type in 2019
Figure 110. Middle East and Africa Nasal Polyposis Drug Market Share by Application in 2019
Figure 111. North America Nasal Polyposis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Nasal Polyposis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Nasal Polyposis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Nasal Polyposis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Nasal Polyposis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Nasal Polyposis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Nasal Polyposis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Nasal Polyposis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Nasal Polyposis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Nasal Polyposis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
経鼻ドラッグデリバリーの世界市場（～2026年） Nasal Drug Delivery is a route of administration in which drugs are insufflated through the nose. It can be a form of either topical administration or systemic administration, as the drugs thus locally delivered can go on to have either purely local or systemic effects. Nasal sprays are locally acti…- 経鼻薬デリバリーシステムの世界市場（～2026年） Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through n…
- 家族性大腸腺腫症治療の世界市場（～2026年） Market Analysis and Insights: Global Familial Adenomatous Polyposis Treatment Market The global Familial Adenomatous Polyposis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Familial Adenomatous Polyposis Tr…
- 経鼻デリバリーの世界市場（～2026年） Market Analysis and Insights: Global Nasal Delivery Market The global Nasal Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Nasal Delivery Scope and Market Size Nasal Delivery market is segmented by Type, and …
- 生体吸収性鼻・耳用包装製品の世界市場（～2026年） Bio-absorbable nasal and ear packing products are made from bio absorbable materials which are used after ear and nose surgery to prevent adhesion of mucosal surfaces. Bio-absorbable ear packing products are used after tympanoplasty, stapes and mastoid surgery, myringoplasty, canalplasty. Bio absorb…